Alexander Pospisil

About Alexander Pospisil

Alexander specialises in banking and finance law, with a particular focus on syndicated lending and acquisition finance.

He regularly advises banks, sponsors and corporates.

Alexander speaks German and English. 

Recent work

• Näder Holding on a €1.1bn debt funds financing 
• Springer Nature on a €2.5bn ESG-linked financing
• Schön Klinik SE on a €350m Term Loan B financing
• Villeroy & Boch on the acquisition financing of Ideal Standard Group
• Busch group on the conclusion of a domination agreement with Pfeiffer Vacuum and financing
• RWE on the acquisition financing of Con Edison Clean Energy Businesses;
• Schön Klinik SE on a €575m syndicated financing
• Alpen Glasfaser GmbH on a €417.5m infrastructure financing
• Grünenthal on the €500m acquisition financing of testosterone business from Bayer
• TeamViewer AG on a new €600m credit line
• The banking consortium on a €4.1bn equivalent acquisition bridge facility for Messer
• The banking consortium on a €1.5bn syndicated, ESG-linked financing for Brenntag SE
• Deutsche Telekom in connection with the €2.15bn capex and revolving credit facilities for Glasfaserplus for the roll-out of its fibre-network in Germany
• Vonovia SE on the acquisition of Deutsche Wohnen SE
• Siemens Energy AG on the acquisition of Siemens Gamesa Renewable Energy, S.A.
• Lanxess AG on the acquisition of US group International Flavors & Fragrances
• Infineon Technologies AG on the acquisition of Cypress Semiconductor Group
• A banking consortium on the financing of the acquisition of Varian Medical Systems by Siemens Healthineers AG
• A banking consortium on the financing of the acquisition of Versum by Merck KGaA
• Hugo Boss AG on its €600m syndicated financing with a sustainability focus
• Grünenthal in the reorganisation of its debt structure (first revolving syndicated loan with sustainability reference)
• BC Partners on the financing of the acquisition of Springer + Business Media for approximately €3.3bn under a covenant-lite/private high-yield structure and in relation to the finance aspects of the subsequent business combination with Macmillan Science and Education to form Springer Nature
• BC Partners on the financing of its acquisition of Aenova Group, the add-on acquisitions of Temmler and Haupt Pharma, and a subsequent refinancing by way of a covenant-lite senior/second-lien structure.